Global Heart Valve Repair and Replacement Devices Market Size By Type (Heart Valve Replacement Devices, Heart Valve Repair Devices), By Application (Hospitals, Clinics), By Region, And Segment Forecas...

The Global Heart Valve Repair and Replacement Devices Market was valued at USD 9.7 billion in 2023 and is projected to reach USD 17.8 billion by 2031, growing at a CAGR of 7.8% during the forecast period from 2023 to 2031. The surge in demand for heart valve therapies stems from the increasing global prevalence of valvular heart diseases (VHD), particularly among aging populations. Minimally invasive procedures, the rise in transcatheter aortic valve replacement (TAVR) adoption, and favorable reimbursement policies are accelerating market growth. Innovations in prosthetic heart valve technology and strong R&D pipelines are expected to further drive expansion across both developed and emerging economies.

Drivers:

1. Growing Burden of Valvular Heart Disease:

The global incidence of heart valve disorders, including aortic stenosis and mitral regurgitation, is increasing significantly, particularly among geriatric populations. This demographic trend is generating higher demand for effective repair and replacement devices.

2. Technological Advancements:

Emerging technologies such as next-generation transcatheter heart valves and robot-assisted surgeries are improving procedural outcomes, reducing recovery time, and expanding patient eligibility.

3. Rise in Minimally Invasive Surgeries (MIS):

The shift toward less invasive heart procedures has led to a higher adoption of TAVR and TMVR (transcatheter mitral valve replacement), boosting the overall device market.

Restraints:

1. High Cost of Procedures and Devices:

Despite their clinical benefits, heart valve replacement devices remain expensive, which can limit accessibility in lower-income regions without adequate healthcare infrastructure or insurance coverage.

2. Procedural Risks and Complications:

Potential risks such as valve malfunction, infection, or thromboembolism can deter patients and providers from opting for surgical or catheter-based interventions.

Opportunity:

1. Expanding Access in Emerging Markets:

Countries in Asia-Pacific, Latin America, and the Middle East are increasing investments in cardiac care, making advanced valve therapies more accessible and affordable.

2. Development of Biocompatible Materials:

Innovations in tissue engineering and the development of anti-calcification coatings offer enhanced durability and compatibility, opening up new growth avenues.

3. Rise in Valve-in-Valve Procedures:

As more patients outlive their initial prosthetic valves, the demand for less invasive valve-in-valve procedures is increasing, particularly among younger patients.

Market by System Type Insights:

Mechanical Heart Valves and Biological Heart Valves are the two key categories. In 2023, Biological Heart Valves led the market owing to their favorable hemodynamic performance and reduced need for long-term anticoagulation therapy. However, Transcatheter Heart Valves are projected to register the highest CAGR, driven by TAVR’s expanding indications and growing patient preference for non-surgical procedures.

Market by End-Use Insights:

Hospitals were the largest end-use segment in 2023, accounting for over 55% of total market share, due to the availability of advanced surgical infrastructure and trained cardiologists. Ambulatory Surgical Centers (ASCs) are expected to grow rapidly as outpatient procedures become more common and technological advancements reduce hospital stay durations.

Market by Regional Insights:

North America dominated the global market in 2023, supported by robust healthcare infrastructure, a high incidence of cardiovascular diseases, and favorable reimbursement policies. Meanwhile, Asia-Pacific is anticipated to witness the fastest growth during the forecast period, driven by increasing healthcare access, government support, and rising awareness of cardiovascular health in countries such as China and India.

Competitive Scenario:

Key players in the Global Heart Valve Repair and Replacement Devices Market include:

Edwards Lifesciences Corporation

Medtronic plc

Abbott Laboratories

Boston Scientific Corporation

LivaNova PLC

CryoLife, Inc.

JenaValve Technology, Inc.

Micro Interventional Devices, Inc.

Artivion, Inc.

Lepu Medical Technology

These players are actively engaging in product launches, regulatory approvals, clinical trials, and strategic collaborations. For instance:

In 2023, Edwards Lifesciences received CE Mark for its SAPIEN X4 TAVR system designed to improve procedural control and valve durability.

Medtronic launched the Evolut FX system in 2024 with enhanced navigability and repositioning features.

Abbott expanded its MitraClip portfolio in 2025 by introducing a next-generation clip delivery system for enhanced mitral valve repair.

Scope of Work – Global Heart Valve Repair and Replacement Devices Market

Report Metric Details

Market Size (2023) USD 9.7 billion

Projected Market Size (2031) USD 17.8 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (Mechanical, Biological, Transcatheter), By End-Use (Hospitals, ASCs), By Region

Growth Drivers Aging population, minimally invasive procedures, technological advancements

Opportunities Valve-in-valve therapy, emerging markets, novel materials

Key Market Developments:

2023: Edwards Lifesciences received CE approval for the SAPIEN X4 valve, expanding its TAVR product portfolio.

2024: Medtronic launched the Evolut FX valve system in the U.S. to enhance placement precision.

2025: Abbott gained FDA clearance for its novel mitral valve repair device aimed at complex mitral regurgitation cases.

FAQs

1) What is the current market size of the Global Heart Valve Repair and Replacement Devices Market?

As of 2023, the market size is valued at USD 9.7 billion.

2) What is the major growth driver of the Global Heart Valve Repair and Replacement Devices Market?

The major growth driver is the rising incidence of valvular heart diseases, coupled with the growing preference for minimally invasive valve therapies.

3) Which is the largest region during the forecast period in the Global Heart Valve Repair and Replacement Devices Market?

North America leads the market, thanks to advanced healthcare systems and widespread adoption of valve interventions.

4) Which segment accounted for the largest market share in Global Heart Valve Repair and Replacement Devices Market?

The Biological Heart Valves segment held the largest market share in 2023 due to increased clinical preference and favorable outcomes.

5) Who are the key market players in the Global Heart Valve Repair and Replacement Devices Market?

Key players include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and LivaNova among others.